China Companion Animal Diagnostics Market is expected to reach US$ 806.73 Million by 2031

Immunodiagnostics Segment to Lead in China Companion Animal Diagnostics Market During 2023–2031

According to our latest study on China Companion Animal Diagnostics Market Forecast to 2031 – by Technique, Product, Application, Companion Animal Type, and End User," the market is expected to grow from US$ 358.61 million in 2023 to US$ 806.73 million by 2031; it is expected to register a CAGR of 9.0% from 2023 to 2031. The report highlights the key factors driving the China companion animal diagnostics market growth and prominent players with their developments in the market. Increasing adoption of artificial intelligence (AI) and machine learning in pet companion animal diagnostics is expected to boost the China companion animal diagnostics market growth over the next 10 years. However, the lack of skilled professionals in veterinary medicine hampers the market growth in the country.

Pets now play a significant role in people's lives. Adopting pets is an essential part of animal welfare since it allows homeless and abandoned animals to have a happy, healthy existence. This is contributing to the rise of a new pet culture where people want to retain pets purely for companionship and to humanize them. In addition, more people are choosing to adopt rather than purchase pets as a result of social media influencers. The Animals Asia Foundation estimates that more than 125 million cats and dogs were owned as pets in metropolitan China in 2023. The increase in pet adoption has made pet parents more aware of their animals' welfare. As a result, pet parents are becoming more conscious of the need to diagnose illnesses, which is promoting the China companion animal diagnostics market size significantly.

China Companion Animal Diagnostics Market, by Product Segment, (%)

Source: The Insight Partners Analysis

Pets' medical requirements are becoming more important as a result of their humanization. Allergies, cancer, and other chronic disorders are common in animals, just like in people. Pet owners' expenditures for their pets' health and well-being are greatly impacted by the rising prevalence of chronic diseases in pets. One out of every 300 dogs in China may have diabetes, according to the Animals Asia Foundation. It is also noted that dogs have a high prevalence rate (1 in 4) of malignant tumors that progress to cancer. Additionally, the ongoing rise in living standards has caused pet parents to become increasingly aware of the unique requirements of their companion animals. Subsequently, the China companion animal diagnostics market is supported by the growth in pet expenditures. Thus, the above-mentioned factors support the China companion animal diagnostics market growth.

In companion animal care, precision medicine is revolutionizing the landscape, offering tailored diagnostics and treatments that may benefit animal welfare and health. Precision medicine enables veterinarians to provide more accurate diagnoses, customized treatments, and improved outcomes using genomic sequencing, personalized diagnostics, and targeted therapies. The advancement of precision medicine in companion animal care will continue to be driven by rapid advancements in technologies such as genome sequencing, gene editing, and targeted therapies. The understanding of animal genetics is expected to be enhanced by the development of more sophisticated tools and techniques to diagnose and treat animals more precisely. As a result of precision medicine in companion animal care, animals at risk for certain diseases can be identified at an early stage, and targeted interventions can be implemented. Owing to this proactive approach, diseases can be prevented or detected at the initial stage when treatments are most effective. Further, nutritional strategies can be developed based on an animal's genetic profile using precision medicine. Companion animal professionals can optimize diets to support animal health, prevent diseases, and improve performance based on an animal's unique nutritional needs and genetic variations. As a result of precision medicine, selective breeding practices can be obtained by identifying genes associated with desirable traits and disease risks. With this knowledge, breeders can make better decisions about breeding, reduce the occurrence of inherited disorders, and increase the genetic diversity of animal populations. Thus, precision medicine in companion animal care could propel the growth of the China companion animal diagnostics market in the future.

China Companion Animal Diagnostics Market Analysis Based on Segmental Evaluation:

The China companion animal diagnostics market report is categorized on the basis of technique, product, application, companion animal type, and end user. Based on technique, the market is segmented into immunodiagnostics, clinical biochemistry, hematology, urinalysis, molecular diagnostics, and others. By product, the China companion animal diagnostics market is bifurcated into instruments and consumables. In terms of application, the market is categorized into bacteriology, clinical pathology, virology, parasitology, and others. Based on companion animal type, the market is divided into dogs, cats, horses, and others. By end user, the market is segmented into diagnostic laboratories, companion animal hospitals and clinics, and research institutes and universities.

In 2023, the immunodiagnostics segment held the largest China companion animal diagnostics market share and is expected to register the highest CAGR during 2023–2031. The immunodiagnostics include tests such as lateral flow assays, ELISA tests, allergen-specific immunodiagnostic tests, and immunoassay analyzers. Owing to the high specificity and sensitivity, these tests are expected to witness rapid growth during 2023–2031. Additionally, clinical biochemistry is expected to account for a significant CAGR, i.e., over 9.0%, as clinical biochemistry can help detect health problems, determine prognosis, and guide physicians toward the right therapy.

In 2023, based on product, the China companion animal diagnostics market is segmented into instruments and consumables. Instruments are designed to facilitate the measurement and detection of various analytes, pathogens, and markers in animals, owing to this is expected to drive the market growth Various instruments used in the diagnostics of companion animals include hematology analyzers, PCR instruments, and imaging systems such as ultrasound, X-ray systems, and MRI machines..

In 2023, the bacteriology segment dominated the market. Bacteriology studies help veterinarians and animal owners identify disease-causing bacteria and fungi by determining the antimicrobial agents to which the bacteria may respond. Although the media culture is the most recognized method in clinical bacteriology, there are an increasing number of diagnostic bacteriology laboratories that use commercial IVD kits in their procedures. There are several real-time PCR test kits, ELISA kits, microspot arrays, and immunofluorescence assays (IFA) that help in the detection and control of infectious diseases in animals caused by bacteria.

ARI Medical Technology Co Ltd, Heska Corp, Innovative Diagnostics SAS, i-SENS Inc, Tianjin LOCMEDT Technologies Co Ltd, Universal Biosensors Inc, Zoetis Inc, Elanco Animal Health Inc, Chengdu Seamaty Technology Co., Ltd, Shenzhen Mindray Animal Medical Technology Co., LTD are among the leading companies operating in the China companion animal diagnostics market.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com